IER5促进卵巢癌细胞的增殖和腹膜传播
Jayaraman Krishnaraj1, Sayaka Ueno2, Moe Nakamura1,3
1Laboratory of Fundamental Oncology, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Cancers
|February 26, 2025
概括
立即早期反应5 (IER5) 基因过度表达驱动卵巢癌 (OC) 的增殖和通过激活热冲击因子-1 (HSF1) 的传播. IER5家族基因可以作为OC的诊断标记和治疗点.
科学领域:
- 妇科瘤学 妇科瘤学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 卵巢癌 (OC) 是一种高度致命的妇科恶性瘤,由于诊断方面的挑战,其生存率很低,特别是在晚期.
- 高度血清性癌,最常见的OC亚型,经常含有p53突变.
- 立即早期反应5 (IER5) 基因是p53的标,在OC中被发现过度表达,但其作用仍然不清楚.
研究的目的:
- 为了研究IER5在卵巢癌中的分子机制.
- 为了确定IER5,热冲击因子-1 (HSF1) 和卵巢癌进展之间的关系.
- 评估IER5作为OC诊断标志物和治疗点的潜力.
主要方法:
- 在正常卵巢细胞与各种OC细胞系 (MOV,ID8G,HM-1) 中对IER5mRNA表达的定量分析.
- 在OC细胞中的IER5表达的比较,从ascites与父细胞系.
- 基因淘汰和过度表达实验,以评估IER5和HSF1对HSP表达和细胞增殖的影响.
主要成果:
- 与正常卵巢细胞相比,OC细胞中的IER5mRNA表达显著更高.
- 亚氏体中的OC细胞表现出较高的IER5表达.
- IER5 knockdown 抑制了 HSP 的上调和 OC 细胞的增殖,而 IER5 的过度表达增强了 HSP 的上调.
- HSF1的淘汰反映了IER5淘汰的影响,表明其关键作用.
结论:
- IER5-HSF1通路与OC细胞的增殖和腹传播有关.
- IER5家族基因的高表达与OC患者预后较差相关.
- IER5家族基因代表了有前途的诊断标记物和卵巢癌的潜在治疗点.
相关概念视频
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K